Morphotek will apply its proprietary Morphodoma antibody technology for the development of novel therapeutic antibodies for use in the treatment of prostate cancer. The NCI will provide its
AcerMed provides comprehensive and advanced electronic medical records (EMR) and practice management software solutions for a range of medical practices, from solo practitioners to multi-site, multi-specialty group practices
Based on the results of this study and a review of such results with its consultant toxicologists, Somaxon intends to proceed with the submission of a new drug
The company said that the funding will help Arcion continue its breakthrough work with ARC-4558, a topical clonidine gel for alleviating moderate and severe pain associated with diabetic
Barr filed an abbreviated new drug application containing a paragraph IV certification for a generic Eloxatin product with the FDA, and following FDA notification of the application’s acceptance
The new offering, called Clarient Insight Dx breast cancer profile, will be sold by Clarient through an exclusive license agreement with Prediction Sciences. The profile is a series
The partnership, initiated in October 2005, is based on ExonHit’s gene expression analysis expertise and intellectual property, and on bioMerieux’s know-how in the field of in vitro diagnostics.
The trial involved 90 healthy male and female volunteers. Doses originally intended for study ranged from 1mg to 160mg, but due to excellent tolerability the maximum dose was
Thomas Hall, NovaMed’s chairman, president and CEO, said: “With over $24 million in gross sales and approximately $2.4 million in net revenue, The Buying Group represented an attractive
The collaboration between Oncology Metrics’s sample procurement network Cure Pace and Cureline is expected to improve the access of industrial and academic researchers to high-quality biospecimens. Olga Potapova,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.